Nattokinase by Allergy Research Group 300 Vegetarian Capsules 50mg per Vegetarian Capsule: Higher Potency NSK-SD™ Formula Our Price: $149.99 Retail Price: $230.75 You Save: $80.76 each, a 35% Savings!
ARG pioneered the introduction of nattokinase to the U.S. market in 2002 (Fibrenase I). All nattokinase is not created equal : We tested recently introduced products and few meet the standards of Dr. Sumi, the discoverer of nattokinase, and Dr. Holsworth, the leading U.S. researcher of nattokinase. ARG offers only the patented NSK-SD™ formulation with no Vitamin K, which is the only form that has been tested for safety . Each batch is tested to ensure potency.*
Isolated, purified and encapsulated nattokinase, an enzyme derived from boiled soybeans and Bacillus subtilis natto . Research has shown nattokinase to support healthy coagulation of blood within normal levels and enhance fibrinolytic activity.*
NSK-SD® is a trademark of Japan BioScience Laboratory.
Highly allergic individuals may want to try the product Lumbrokinase (Fibrenase III) .* (Related products appear on the right side of this page).
Additional Sizes Available
300 Softgels - 72 mg of Nattokinase
300 Vegetarian Capsules - 100 mg of Nattokinase
90 Softgels - 72 mg of Nattokinase
90 Vegetarian Capsules - 100 mg of Nattokinase
Supplement Facts
Two (2) Vegetarian Capsules Contain:
Amount Per Serving
Nattokinase (Nattokinase NSK-SD) 2000 FU 100 mg
L-Leucine, Hydroxypropyl Methylcellulose, Cellulose
As a dietary supplement, two (2) capsules, two times (2x) daily initial dose, or as directed by a healthcare practitioner. May be taken with or without food. Take with 8-10 ounces of water.
If taken with anticoagulant drugs, use under medical supervision. Contraindicated in any condition associated with bleeding.
Blood Builder , Fibrolytic , Vascular Health
Blood Coagulation , Fibrocystic disease - breast , Fibrositis
Blood , Breast , Circulatory system
Absorbed , Hardened , Resigned
Fujita M, Hong K, Ito Y, Misawa S, Takeuchi N, Kariya K, Nishimuro S. Biol Pharm Bull 1995 Sep;18(9):1194-6 Biotechnology Research Laboratories, JCR Pharmaceuticals Co., Ltd., Kobe, Japan. Intraduodenal administration of nattokinase (NK) at a dose of 80 mg/kg, resulted in the degradation of fibrinogen in plasma suggesting transport of NK across the intestinal tract in normal rats. The action of NK on the cleavage of fibrinogen in the plasma from blood samples drawn at intervals after intraduodenal administration of the enzyme was investigated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blotting analysis with an anti-fibrinogen gamma chain antibody. In parallel with the degradation process, plasma recalcification times were remarkably prolonged NK was also detected in the plasma from blood samples drawn 3 and 5 h after administration of the enzyme by SDS-PAGE and Western blotting analysis with an anti-NK antibody. The results indicate that NK is absorbed from the rat intestinal tract and that NK cleaves fibrinogen in plasma after intraduodenal administration of the enzyme.*
Detailed Technical Information
Our Price: $149.99 Retail Price: $230.75 You Save: $80.76 each, a 35% Savings!